_id
691857ff3c536f8df2317a99
Ticker
0K1R.LSE
Name
Viridian Therapeutics Inc.
Exchange
LSE
Address
221 Crescent Street, Waltham, MA, United States, 02453
Country
UK
Sector
Industry
Currency
USD
Website
https://www.viridiantherapeutics.com
Description
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Last Close
30.68
Volume
42
Current Price
30.68
Change
0.7058
Last Updated
2026-01-08T14:12:18.217Z
Image
https://logo.clearbit.com/www.viridiantherapeutics.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
70570000
Cost Of Revenue
-
Gross Profit
70570000
Operating Expenses
110583000
Operating Income
-40013000
Interest Expense
560000
Pretax Income
-34599000
Net Income
-34599000
Eps
-0.423050827761383
Dividends Per Share
-
Shares Outstanding
30839500
Income Tax Expense
-
EBITDA
-33929000
Operating Margin
-56.69973076378064
Total Other Income Expense Net
5414000
Cash
169647000
Short Term Investments
321254000
Receivables
70000000
Inventories
-
Total Current Assets
571913000
Property Plant Equipment
3707000
Total Assets
577138000
Payables
10063000
Short Term Debt
730000
Long Term Debt
-
Total Liabilities
74168000
Equity
502970000
Bs_currency_symbol
-
Depreciation
110000
Change In Working Capital
-60328000
Cash From Operations
-84611000
Capital Expenditures
127000
Cash From Investing
126077000
Cash From Financing
10857000
Net Change In Cash
52323000
Cf_currency_symbol
-
PE
-
PB
4.98866419333161
ROE
-6.87893910173569
ROA
-5.994926689977094
FCF
-84738000
Fcf Percent
-1.2007651976760663
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
70570000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
70570000
Quarters > 0 > income Statement > operating Expenses
110583000
Quarters > 0 > income Statement > operating Income
-40013000
Quarters > 0 > income Statement > interest Expense
560000
Quarters > 0 > income Statement > pretax Income
-34599000
Quarters > 0 > income Statement > net Income
-34599000
Quarters > 0 > income Statement > eps
-0.423050827761383
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
81784499
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-33929000
Quarters > 0 > income Statement > operating Margin
-56.69973076378064
Quarters > 0 > income Statement > total Other Income Expense Net
5414000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
169647000
Quarters > 0 > balance Sheet > short Term Investments
321254000
Quarters > 0 > balance Sheet > receivables
70000000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
571913000
Quarters > 0 > balance Sheet > property Plant Equipment
3707000
Quarters > 0 > balance Sheet > total Assets
577138000
Quarters > 0 > balance Sheet > payables
10063000
Quarters > 0 > balance Sheet > short Term Debt
730000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
74168000
Quarters > 0 > balance Sheet > equity
502970000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-34599000
Quarters > 0 > cash Flow > depreciation
110000
Quarters > 0 > cash Flow > change In Working Capital
-60328000
Quarters > 0 > cash Flow > cash From Operations
-84611000
Quarters > 0 > cash Flow > capital Expenditures
127000
Quarters > 0 > cash Flow > cash From Investing
126077000
Quarters > 0 > cash Flow > cash From Financing
10857000
Quarters > 0 > cash Flow > net Change In Cash
52323000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.423050827761383
Quarters > 0 > ratios > PB
4.98866419333161
Quarters > 0 > ratios > ROE
-6.87893910173569
Quarters > 0 > ratios > ROA
-5.994926689977094
Quarters > 0 > ratios > FCF
-84738000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.2007651976760663
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
75000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
75000
Quarters > 1 > income Statement > operating Expenses
106842000
Quarters > 1 > income Statement > operating Income
-106767000
Quarters > 1 > income Statement > interest Expense
514000
Quarters > 1 > income Statement > pretax Income
-100735000
Quarters > 1 > income Statement > net Income
-100735000
Quarters > 1 > income Statement > eps
-1.2345964529045665
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
81593463
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-100108000
Quarters > 1 > income Statement > operating Margin
-142356
Quarters > 1 > income Statement > total Other Income Expense Net
6032000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
117324000
Quarters > 1 > balance Sheet > short Term Investments
446032000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
578750000
Quarters > 1 > balance Sheet > property Plant Equipment
3068000
Quarters > 1 > balance Sheet > total Assets
582324000
Quarters > 1 > balance Sheet > payables
8518000
Quarters > 1 > balance Sheet > short Term Debt
8988000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
67155000
Quarters > 1 > balance Sheet > equity
515169000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-100735000
Quarters > 1 > cash Flow > depreciation
113000
Quarters > 1 > cash Flow > change In Working Capital
15865000
Quarters > 1 > cash Flow > cash From Operations
-75373000
Quarters > 1 > cash Flow > capital Expenditures
42000
Quarters > 1 > cash Flow > cash From Investing
75718000
Quarters > 1 > cash Flow > cash From Financing
764000
Quarters > 1 > cash Flow > net Change In Cash
1109000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.2345964529045665
Quarters > 1 > ratios > PB
4.859157761511271
Quarters > 1 > ratios > ROE
-19.553777498257855
Quarters > 1 > ratios > ROA
-17.29878899032154
Quarters > 1 > ratios > FCF
-75415000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1005.5333333333333
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
72000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
72000
Quarters > 2 > income Statement > operating Expenses
93938000
Quarters > 2 > income Statement > operating Income
-93866000
Quarters > 2 > income Statement > interest Expense
586000
Quarters > 2 > income Statement > pretax Income
-86912000
Quarters > 2 > income Statement > net Income
-86912000
Quarters > 2 > income Statement > eps
-1.0684482792576044
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
81344134
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-86209000
Quarters > 2 > income Statement > operating Margin
-130369.44444444444
Quarters > 2 > income Statement > total Other Income Expense Net
6954000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
116215000
Quarters > 2 > balance Sheet > short Term Investments
520418000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
657238000
Quarters > 2 > balance Sheet > property Plant Equipment
3254000
Quarters > 2 > balance Sheet > total Assets
660981000
Quarters > 2 > balance Sheet > payables
3886000
Quarters > 2 > balance Sheet > short Term Debt
536000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
56508000
Quarters > 2 > balance Sheet > equity
604473000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-86912000
Quarters > 2 > cash Flow > depreciation
117000
Quarters > 2 > cash Flow > change In Working Capital
-13855000
Quarters > 2 > cash Flow > cash From Operations
-92653000
Quarters > 2 > cash Flow > capital Expenditures
86000
Quarters > 2 > cash Flow > cash From Investing
100062000
Quarters > 2 > cash Flow > cash From Financing
9212000
Quarters > 2 > cash Flow > net Change In Cash
16621000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.0684482792576044
Quarters > 2 > ratios > PB
4.128617872295371
Quarters > 2 > ratios > ROE
-14.378144267816758
Quarters > 2 > ratios > ROA
-13.148940741110563
Quarters > 2 > ratios > FCF
-92739000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1288.0416666666667
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
72000
Quarters > 3 > income Statement > cost Of Revenue
123000
Quarters > 3 > income Statement > gross Profit
72000
Quarters > 3 > income Statement > operating Expenses
87544000
Quarters > 3 > income Statement > operating Income
-87472000
Quarters > 3 > income Statement > interest Expense
858000
Quarters > 3 > income Statement > pretax Income
-79725000
Quarters > 3 > income Statement > net Income
-79725000
Quarters > 3 > income Statement > eps
-0.9959136249265994
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
80052123
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-78744000
Quarters > 3 > income Statement > operating Margin
-121488.88888888889
Quarters > 3 > income Statement > total Other Income Expense Net
7747000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
99594000
Quarters > 3 > balance Sheet > short Term Investments
617990000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
738461000
Quarters > 3 > balance Sheet > property Plant Equipment
3441000
Quarters > 3 > balance Sheet > total Assets
742403000
Quarters > 3 > balance Sheet > payables
2143000
Quarters > 3 > balance Sheet > short Term Debt
513000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
70764000
Quarters > 3 > balance Sheet > equity
671639000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-79725000
Quarters > 3 > cash Flow > depreciation
123000
Quarters > 3 > cash Flow > change In Working Capital
460000
Quarters > 3 > cash Flow > cash From Operations
-73332000
Quarters > 3 > cash Flow > capital Expenditures
114000
Quarters > 3 > cash Flow > cash From Investing
-62915000
Quarters > 3 > cash Flow > cash From Financing
35524000
Quarters > 3 > cash Flow > net Change In Cash
-100723000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.9959136249265994
Quarters > 3 > ratios > PB
3.6567250169212926
Quarters > 3 > ratios > ROE
-11.870215994008685
Quarters > 3 > ratios > ROA
-10.738776648262467
Quarters > 3 > ratios > FCF
-73446000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1020.0833333333334
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
302000
Annuals > 0 > income Statement > cost Of Revenue
1240000
Annuals > 0 > income Statement > gross Profit
302000
Annuals > 0 > income Statement > operating Expenses
299337000
Annuals > 0 > income Statement > operating Income
-299035000
Annuals > 0 > income Statement > interest Expense
3046000
Annuals > 0 > income Statement > pretax Income
-269949000
Annuals > 0 > income Statement > net Income
-269949000
Annuals > 0 > income Statement > eps
-3.9765047285154522
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
67886000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-265663000
Annuals > 0 > income Statement > operating Margin
-99018.21192052981
Annuals > 0 > income Statement > total Other Income Expense Net
29086000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
99594000
Annuals > 0 > balance Sheet > short Term Investments
617990000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
738461000
Annuals > 0 > balance Sheet > property Plant Equipment
3441000
Annuals > 0 > balance Sheet > total Assets
742403000
Annuals > 0 > balance Sheet > payables
2143000
Annuals > 0 > balance Sheet > short Term Debt
513000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
70764000
Annuals > 0 > balance Sheet > equity
671639000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-269949000
Annuals > 0 > cash Flow > depreciation
540000
Annuals > 0 > cash Flow > change In Working Capital
9598000
Annuals > 0 > cash Flow > cash From Operations
-232319000
Annuals > 0 > cash Flow > capital Expenditures
511000
Annuals > 0 > cash Flow > cash From Investing
-228651000
Annuals > 0 > cash Flow > cash From Financing
457737000
Annuals > 0 > cash Flow > net Change In Cash
-3233000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-3.9765047285154522
Annuals > 0 > ratios > PB
3.1009850232044296
Annuals > 0 > ratios > ROE
-40.19257368913956
Annuals > 0 > ratios > ROA
-36.361517935676446
Annuals > 0 > ratios > FCF
-232830000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-770.9602649006622
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
314000
Annuals > 1 > income Statement > cost Of Revenue
1322000
Annuals > 1 > income Statement > gross Profit
314000
Annuals > 1 > income Statement > operating Expenses
254764000
Annuals > 1 > income Statement > operating Income
-254450000
Annuals > 1 > income Statement > interest Expense
1847000
Annuals > 1 > income Statement > pretax Income
-237734000
Annuals > 1 > income Statement > net Income
-237734000
Annuals > 1 > income Statement > eps
-5.3118417355641965
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
44755475
Annuals > 1 > income Statement > income Tax Expense
18563000
Annuals > 1 > income Statement > EBITDA
-235365000
Annuals > 1 > income Statement > operating Margin
-81035.03184713375
Annuals > 1 > income Statement > total Other Income Expense Net
16716000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
102827000
Annuals > 1 > balance Sheet > short Term Investments
374543000
Annuals > 1 > balance Sheet > receivables
102000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
486478000
Annuals > 1 > balance Sheet > property Plant Equipment
3342000
Annuals > 1 > balance Sheet > total Assets
490424000
Annuals > 1 > balance Sheet > payables
2239000
Annuals > 1 > balance Sheet > short Term Debt
843000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
48402000
Annuals > 1 > balance Sheet > equity
442022000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-237734000
Annuals > 1 > cash Flow > depreciation
522000
Annuals > 1 > cash Flow > change In Working Capital
-9425000
Annuals > 1 > cash Flow > cash From Operations
-184170000
Annuals > 1 > cash Flow > capital Expenditures
898000
Annuals > 1 > cash Flow > cash From Investing
-94252000
Annuals > 1 > cash Flow > cash From Financing
225670000
Annuals > 1 > cash Flow > net Change In Cash
-52752000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.3118417355641965
Annuals > 1 > ratios > PB
3.10640188271172
Annuals > 1 > ratios > ROE
-53.78329585405252
Annuals > 1 > ratios > ROA
-48.47519697241571
Annuals > 1 > ratios > FCF
-185068000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-589.3885350318471
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1772000
Annuals > 2 > income Statement > cost Of Revenue
755000
Annuals > 2 > income Statement > gross Profit
1772000
Annuals > 2 > income Statement > operating Expenses
136076000
Annuals > 2 > income Statement > operating Income
-134304000
Annuals > 2 > income Statement > interest Expense
486000
Annuals > 2 > income Statement > pretax Income
-129874000
Annuals > 2 > income Statement > net Income
-129874000
Annuals > 2 > income Statement > eps
-4.0475212415082815
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
32087293
Annuals > 2 > income Statement > income Tax Expense
-4430000
Annuals > 2 > income Statement > EBITDA
-129133000
Annuals > 2 > income Statement > operating Margin
-7579.232505643341
Annuals > 2 > income Statement > total Other Income Expense Net
4430000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
155579000
Annuals > 2 > balance Sheet > short Term Investments
268971000
Annuals > 2 > balance Sheet > receivables
102000
Annuals > 2 > balance Sheet > inventories
-6623000
Annuals > 2 > balance Sheet > total Current Assets
424550000
Annuals > 2 > balance Sheet > property Plant Equipment
2936000
Annuals > 2 > balance Sheet > total Assets
435091000
Annuals > 2 > balance Sheet > payables
14234000
Annuals > 2 > balance Sheet > short Term Debt
613000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
40027000
Annuals > 2 > balance Sheet > equity
395064000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-129874000
Annuals > 2 > cash Flow > depreciation
255000
Annuals > 2 > cash Flow > change In Working Capital
15962000
Annuals > 2 > cash Flow > cash From Operations
-93838000
Annuals > 2 > cash Flow > capital Expenditures
797000
Annuals > 2 > cash Flow > cash From Investing
-115126000
Annuals > 2 > cash Flow > cash From Financing
322244000
Annuals > 2 > cash Flow > net Change In Cash
113280000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.0475212415082815
Annuals > 2 > ratios > PB
2.4918447371565113
Annuals > 2 > ratios > ROE
-32.874167223538464
Annuals > 2 > ratios > ROA
-29.849847503166004
Annuals > 2 > ratios > FCF
-94635000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-53.40575620767494
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2963000
Annuals > 3 > income Statement > cost Of Revenue
620000
Annuals > 3 > income Statement > gross Profit
2963000
Annuals > 3 > income Statement > operating Expenses
82691000
Annuals > 3 > income Statement > operating Income
-79728000
Annuals > 3 > income Statement > interest Expense
3000
Annuals > 3 > income Statement > pretax Income
-79413000
Annuals > 3 > income Statement > net Income
-79413000
Annuals > 3 > income Statement > eps
-6.662884378781868
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
11918712
Annuals > 3 > income Statement > income Tax Expense
3000
Annuals > 3 > income Statement > EBITDA
-79290000
Annuals > 3 > income Statement > operating Margin
-2690.786365170435
Annuals > 3 > income Statement > total Other Income Expense Net
315000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
42299000
Annuals > 3 > balance Sheet > short Term Investments
154666000
Annuals > 3 > balance Sheet > receivables
451000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
200163000
Annuals > 3 > balance Sheet > property Plant Equipment
2055000
Annuals > 3 > balance Sheet > total Assets
203709000
Annuals > 3 > balance Sheet > payables
2329000
Annuals > 3 > balance Sheet > short Term Debt
520000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
15993000
Annuals > 3 > balance Sheet > equity
187716000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-79413000
Annuals > 3 > cash Flow > depreciation
120000
Annuals > 3 > cash Flow > change In Working Capital
1724000
Annuals > 3 > cash Flow > cash From Operations
-54581000
Annuals > 3 > cash Flow > capital Expenditures
338000
Annuals > 3 > cash Flow > cash From Investing
-74292000
Annuals > 3 > cash Flow > cash From Financing
125275000
Annuals > 3 > cash Flow > net Change In Cash
-3598000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-6.662884378781868
Annuals > 3 > ratios > PB
1.9479750482643994
Annuals > 3 > ratios > ROE
-42.30486479575529
Annuals > 3 > ratios > ROA
-38.98355006406197
Annuals > 3 > ratios > FCF
-54919000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-18.534930813364834
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.423050827761383
Valuation > metrics > PB
4.98866419333161
Valuation > final Score
30.113358066683897
Valuation > verdict
66.3% Overvalued
Profitability > metrics > ROE
-6.87893910173569
Profitability > metrics > ROA
-6.049696369902415
Profitability > metrics > Net Margin
-0.4902791554484909
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1474600870827286
Risk > metrics > Interest Coverage
-71.45178571428572
Risk > final Score
-226
Risk > verdict
High
Liquidity > metrics > Current Ratio
52.98925229315297
Liquidity > metrics > Quick Ratio
52.98925229315297
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
31.40842238488729
Prev Valuations > 1
38.713821277046286
Prev Valuations > 2
43.432749830787074
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-771
Prev Risks > 1
-581
Prev Risks > 2
-348
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:54:53.764Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-1
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4231
Earnings History > 1 > eps Estimate
-0.94
Earnings History > 1 > eps Difference
0.5169
Earnings History > 1 > surprise Percent
54.9894
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.0047
Earnings History > 2 > eps Estimate
-0.97
Earnings History > 2 > eps Difference
-0.0347
Earnings History > 2 > surprise Percent
-3.5773
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.869
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.9959
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-11
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-1.1546
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.0178
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.7945
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-1.3458
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-12-18
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-1.0918
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.273
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-1.6133
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-08
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.1293
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.8566
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-15
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-1.0623
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.9834
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-10
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-1.3092
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-08
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-1.2557
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-2.2159
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-2.9134
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-23.0724
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-1.4772
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-1.8186
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-2.6532
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-4.6871
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-5.4196
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-4.3068
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-5.6477
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-5.0181
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-4.3994
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-4.3145
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-2.64
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Viridian Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1
Date
2025-09-30
EPS Actual
-0.4231
EPS Estimate
-0.94
EPS Difference
0.5169
Surprise Percent
54.9894%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.